Showing results (191-200 of 523) with videos related to
Sort By:
Pageof 53
Cancers|March 29, 2023
Overview of Trop-2 in Cancer: From Pre-Clinical Studies to Future Directions in Clinical SettingsPasquale Lombardi, Marco Filetti, Rosa Falcone, et al.Current Treatment Options in Oncology|February 22, 2019
Malignant Pleural Mesothelioma: Is Tailoring the Second-Line Therapy Really "Raising the Bar?"Vincenzo Di Noia, Emanuele Vita, Miriam Ferrara, et al.Cancer Treatment Reviews|March 21, 2022
New first-line immunotherapy-based combinations for metastatic renal cell carcinoma: A systematic review and network meta-analysisPasquale Lombardi, Marco Filetti, Rosa Falcone, et al.Cancer Treatment Reviews|February 17, 2015
Balancing activity and tolerability of neoadjuvant paclitaxel- and docetaxel-based chemotherapy for HER2-positive early stage breast cancer: sensitivity analysis of randomized trialsLuisa Carbognin, Isabella Sperduti, Rolando Nortilli, et al.World Journal of Gastroenterology|August 1, 2013
First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancerVanja Vaccaro, Emilio Bria, Isabella Sperduti, et al.Lung Cancer (Amsterdam, Netherlands)|June 21, 2008
Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trialsEmilio Bria, Richard J Gralla, Harry Raftopoulos, et al.Anti-Cancer Agents in Medicinal Chemistry|October 21, 2014
Neoadjuvant strategies for triple negative breast cancer: 'state-of-the-art' and future perspectivesLuisa Carbognin, Jenny Furlanetto, Cecilia Vicentini, et al.Cancer Genetics|September 14, 2015
An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutationMitchell Cheung, Yuwaraj Kadariya, Jianming Pei, et al.Life Sciences|April 28, 2015
Contribution of sensory nerves to LPS-induced hyperresponsiveness of human isolated bronchiLuigino Calzetta, Livio Luongo, Mario Cazzola, et al.Cancer|January 24, 2007
Sequential chemotherapy in nonsmall-cell lung cancer: cisplatin and gemcitabine followed by docetaxelAnna Ceribelli, Maria S Pino, Alain J Gelibter, et al.Pageof 53